Palo Alto, CA, United States of America

Graeme Richard Martin

This inventor holds 3 USPTO granted patents. Top assignees: Glaxo Wellcome Inc., The Wellcome Foundation Limited. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Graeme Richard Martin. Retrieved from https://idiyas.com/inventor/graeme-richard-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Graeme Richard Martin: Innovator in Therapeutic Compounds

Introduction

Graeme Richard Martin is a notable inventor based in Palo Alto, CA (US). He has made significant contributions to the field of therapeutic compounds, holding a total of 3 patents. His work focuses on innovative chemical compounds that have potential applications in medicine.

Latest Patents

Among his latest patents are the following:

1. Therapeutic heterocyclic compounds - These compounds are defined by a specific formula wherein R and R¹ can be hydrogen, C₁-₄ alkyl, or linked to form a ring.

2. Indole derivatives as 5-HT agonists - This patent also describes compounds of a particular formula where R and R¹ can take similar forms as mentioned above.

Career Highlights

Throughout his career, Graeme has worked with prominent organizations such as Glaxo Wellcome Inc. and The Wellcome Foundation Limited. His experience in these companies has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Graeme has collaborated with esteemed colleagues, including Robert Charles Glen and David Lawrence Selwood. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Graeme Richard Martin is a distinguished inventor whose work in therapeutic compounds has the potential to impact the medical field significantly. His innovative patents and collaborations highlight his commitment to advancing science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…